Publications and communications of Michel Malaise

Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6

Massenet, T., Guiot, J., Zanella, D., Dejong, T., GILTAY, L., Henket, M., GUISSARD, F., André, B., Malaise, M., Potjewijd Judith, Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (29 March 2023). Etude métabolomique de l’air exhalé pour diagnostiquer la sclérodermie systémique par chromatographie gazeuse bidimensionnelle exhaustive [Paper presentation]. SEP 23, Paris, France.

Malaise, O., André, C., Van Durme, C., Seidel, L., Schleich, F., Louis, R., Malaise, M., & Ribbens, C. (20 March 2023). Lung Function Impairment, Associating Hyperinflation with Impaired Diffusion Capacity and Transfer Coefficient, Is a Risk Factor for Hip Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine, 12 (6), 2383. doi:10.3390/jcm12062383

Guiot, J., Henket, M., Ernst, M., Seidel, L., WINANDY, M.-L., DENIS, A., Frix, A.-N., GESTER, F., THYS, M., GILTAY, L., Garah, O., Njock, M.-S., CANIVET, P., Meunier, P., Corhay, J.-L., Regnier, C., Malaise, O., Malaise, M., & Louis, R. (09 March 2023). Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis. Frontiers in Medicine, 10. doi:10.3389/fmed.2023.1063012

Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., Louis, R., & Focant, J.-F. (2023). A Journey over Current Usage of GC×GC -TOFMS in Metabolomic [Paper presentation]. GCxGC & GCTOF metabonomics Webinar.

Salpetier, P., Mina, M., Seidel, L., LEROY, M., LEONORI, L., Malaise, M., Ribbens, C., & Malaise, O. (2022). Réalisation « systématique » ou « basée sur les recommandations » d’une radiographie du rachis dorsolombaire (Vertebral Fracture Assessment) lors d’un examen de densitométrie osseuse ? Revue du Rhumatisme. doi:10.1016/j.rhum.2022.10.152

DENIS, A., Henket, M., Ernst, M., Maes, N., THYS, M., Regnier, C., Malaise, O., Frix, A.-N., GESTER, F., DESIR, C., Meunier, P., Louis, R., Malaise, M., & Guiot, J. (30 November 2022). Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.1024298

Denis, A., Regnier, C., Henket, M., Maes, N., THYS, M., Louis, R., Malaise, M., & Guiot, J. (September 2022). Airflow obstruction as a marker of prognosis in rheumatoid arthritis [Poster presentation]. ERS International Congress 2022, Barcelone, Spain. doi:10.1183/13993003.congress-2022.2411

CHAUVEHEID, F., Von Frenckell, C., Colin, G., DEFLANDRE, E., Piette, Y., Duysinx, B., Bianchi, E., Malaise, M., & Malaise, O. (July 2022). Poussée sévère d’une dermatomyosite pré-existante chez une patiente avec un adénocarcinome pulmonaire traité par pembrolizumab, un anti-PD-1. Revue Médicale de Liège, 77 (7-8), 462-467.

Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Judith Potjewijd, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (18 May 2022). BREATHOMICS APPROACH TO INVESTIGATE SYSTEMIC SCLEROSIS USING THERMAL DESORPTION AND COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY HIGH-RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETRY [Poster presentation]. 17th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-17), Gand, Belgium.

Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., DiGiovanni, N., GILTAY, L., HENKET, M., GUISSARD, F., SCHLEICH, F., GUIOT, J., ANDRE, B., MALAISE, M., Potjewijd, J., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (May 2022). Recent advances in medical applications of GC×GC [Paper presentation]. HTC-17, Ghent, Belgium.

Mina, M., Bolland, M., MALAISE, O., Pottier, L., POIRRIER, A.-L., TOMBU, S., & MALAISE, M. (21 March 2022). Les vascularites à ANCA chez les consommateurs de cocaïne : de la poudre aux yeux ? [Paper presentation]. GLEM ORL, Liege, Belgium.

Mina, M., Bolland, M., MALAISE, O., Pottier, L., POIRRIER, A.-L., TOMBU, S., & MALAISE, M. (21 March 2022). Les vascularites à ANCA chez les consommateurs de cocaïne : de la poudre aux yeux ? [Paper presentation]. GLEM ORL, Liege, Belgium.

MALAISE, O., GERARD, C., CHAUVEHEID, F., Salpetier, P., SEIDEL, L., RINKIN, C., & MALAISE, M. (2022). VOLUMETRIC BONE MINERAL DENSITY AND BONE MICRO-ARCHITECTURE, ANALYZED WITH HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (HR-pQCT), CORRELATE WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS. Osteoporosis International.

Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd Judith, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (01 February 2022). TD-GC×GC-HRTOFMS to investigate pulmonary fibrosis in patients [Poster presentation]. Multidimensional Chromatography Worshop 2022.

DE SENY, D., Baiwir, D., BIANCHI, E., COBRAIVILLE, G., DEROYER, C., Poulet, C., MALAISE, O., PAULISSEN, G., KAISER, M.-J., Hauzer, J.-P., Mazzucchelli, G., DELVENNE, P., & MALAISE, M. (2022). New Proteins Contributing to Immune Cell Infiltration and Pannus Formation of Synovial Membrane from Arthritis Diseases. International Journal of Molecular Sciences, 23 (1), 434. doi:10.3390/ijms23010434

DEROYER, C., Poulet, C., PAULISSEN, G., Ciregia, F., MALAISE, O., PLENER, Z., COBRAIVILLE, G., DANIEL, C., GILLET, P., MALAISE, M., & DE SENY, D. (2022). CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane. Cellular and Molecular Life Sciences. doi:10.1007/s00018-022-04282-6

Focant, J.-F., Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di Giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., & Louis, R. (2022). Exploring Volatolomes with GC×GC-TOFMS [Paper presentation]. Analytics Nantes 2022, Nantes, France.

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboundjian, M., Costes, B., Verdonk, P., Brands, G., Brasseur, J., Urbin-Choffray, D., Vandenberghe, M., Brabants, K., De Vlam, K., Fache, W., Jandrain, B., Grek, V., MALAISE, M., & Henrotin, Y. (2022). An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis. Therapeutic Advances in Musculoskeletal Disease, 14, 1759720X211070205. doi:10.1177/1759720X211070205

MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., MALAISE, M., CAVALIER, E., DELANAYE, P., & BOUQUEGNEAU, A. (2022). BONE MINERAL DENSITY AND BONE MICRO-ARCHITECTURE EVOLUTION AFTER KIDNEY TRANSPLANTATION: 3-MONTHS RESULTS OF A PROSPECTIVE COHORT STUDY. Osteoporosis International.

Mina, M., JACQUERIE, P., DUQUENNE, J. B., LAVIGNE, J.-P., BOULANGER, Y.-G., BISOGNI, C., Derwael, C., WITHOFS, N., MALAISE, M., & MALAISE, O. (2022). Périostite bilatérale et polyarthrite : à propos d'un cas d'ostéoarthropathie hypertrophique pneumique. Revue Médicale de Liège.

MALAISE, O., CHAUVEHEID, F., GERARD, C., SEIDEL, L., RINKIN, C., & MALAISE, M. (December 2021). Imagerie optique par HandScan dans la métrologie de la polyarthrite rhumatoïde : étude des capacités de prédiction de la rémission clinique et échographique. Revue du Rhumatisme, 88 (S1), 32-A33. doi:10.1016/j.rhum.2021.10.045

MALAISE, O., PAULISSEN, G., DEROYER, C., Cirgea, F., Poulet, C., LECHANTEUR, C., Brondello, J.-M., DE SENY, D., & MALAISE, M. (December 2021). Influence des glucocorticoïdes sur les caractéristiques de la sénescence cellulaire dans les fibroblastes synoviaux d’origine arthrosique. Revue du Rhumatisme, 88 (S1), 157.

MALAISE, O.* , PAULISSEN, G.* , DEROYER, C., Ciregia, F., Poulet, C., NEUVILLE, S., PLENER, Z., DANIEL, C., Gillet, P., LECHANTEUR, C., Brondello, J.-M., DE SENY, D.* , & MALAISE, M.*. (16 November 2021). Influence of Glucocorticoids on Cellular Senescence Hallmarks in Osteoarthritic Fibroblast-like Synoviocytes. Journal of Clinical Medicine, 10 (22), 5331. doi:10.3390/jcm10225331
* These authors have contributed equally to this work.

Jouret, M., RINKIN, C., SEGHAYE, M.-C., & MALAISE, M. (October 2021). À propos d’une cohorte de jeunes patients suivis dans le service de rhumatologie adulte du CHU de Liège. Revue Médicale de Liège, 76 (10), 741-745.

Mina, M., Bolland, M., Pottier, L., TOMBU, S., POIRRIER, A.-L., MALAISE, M., & MALAISE, O. (September 2021). LOCALIZED NECROTIZING VASCULITIS AMONG COCAINE USUERS : SMOKE AND MIRROS ? [Paper presentation]. Belgian congress of rheumatology.

CIREGIA, F., Nys, G., Cobraiville, G., Badot, V., Di Romana, S., Sidiras, P., Sokolova, T., Durez, P., Fillet, M., Malaise, M., & de Seny, D. (2021). A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis. Frontiers in Immunology. doi:10.3389/fimmu.2021.638814

JACQUERIE, P., HENKET, M., André, B., MOERMANS, C., DE SENY, D., GESTER, F., LOUIS, R., MALAISE, M., & GUIOT, J. (21 May 2021). Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers. Scientific Reports, 11 (1), 10679. doi:10.1038/s41598-021-87701-1

Zanella, D., GUIOT, J., Stefanuto, P.-H., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Pojtewijd, J., SCHLEICH, F., Louis, R., & Focant, J.-F. (2021). Breathomics to diagnose systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03333-4

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., MALAISE, M., & MALAISE, O. (March 2021). Systematic analysis of Covid-19 infection and symptoms in a systemic lupus erythematous population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments [Paper presentation]. Belgian congress of rheumatology 2021.

Ciregia, F., DEROYER, C., COBRAIVILLE, G., PLENER, Z., MALAISE, O., GILLET, P., Fillet, M., MALAISE, M., & DE SENY, D. (2021). Modulation of αVβ6 integrin in osteoarthritis-related synovitis and the interaction with VTN (381-397 a.a.) competing for TGF-β1 activation. Experimental and Molecular Medicine. doi:10.1038/s12276-021-00558-2

CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044

DEROYER, C., CIREGIA, F., MALAISE, O., PAULISSEN, G., Poulet, C., Malaise, M., & DE SENY, D. (2021). Fibrosis in osteoarthritis – Role of Cemip [Paper presentation]. Fibrosis in immune-mediated inflammatory diseases : from pathophysiology to innovative treatment.

GUIOT, J., NJOCK, M.-S., ANDRE, B., GESTER, F., HENKET, M., DE SENY, D., MOERMANS, C., MALAISE, M., & LOUIS, R. (2021). Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction. Scientific Reports, 11 (1), 10882. doi:10.1038/s41598-021-90333-0

Hick, A.-C., Malaise, M., Loeuille, D., Conrozier, T., Maugars, Y., Pelousse, F., Tits, C., & Henrotin, Y. (2021). Cartilage Biomarkers Coll2-1 and Coll2-1NO2 Are Associated with Knee OA MRI Features and Are Helpful in Identifying Patients at Risk of Disease Worsening. Cartilage. doi:10.1177/19476035211021892

Parzibut, G., Henket, M., Moermans, C., Struman, I., Louis, E., Malaise, M., Louis, R., Misset, B., NJOCK, M.-S.* , & Guiot, J.*. (2021). A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome. Frontiers in Molecular Biosciences, 8, 640042. doi:10.3389/fmolb.2021.640042
* These authors have contributed equally to this work.

RELIC, B., DEROYER, C., MALAISE, O., Plener, Z., Gillet, P., de Seny, D., & Malaise, M. (2021). TFEB phosphorylation on Serine 211 is induced by autophagy in human synovial fibroblasts and by p62/SQSTM1 overexpression in HEK293 cells. Biochemical Journal, 478 (16), 3145-3155. doi:10.1042/BCJ20210174

Rinkin, C., Fosse, P., MALAISE, O., Chapelier, N., Horrion, J., Seidel, L., Albert, A., Hustinx, R., & Malaise, M. (2021). Dissociation between 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission. BMC Rheumatology, 5 (1), 31. doi:10.1186/s41927-021-00196-1

Zanella, D., GUIOT, J., Stefanuto, P.-H., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd, J., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (2021). TD-GC×GC-HRTOFMS for Breath Profiling of Systemic Sclerosis. In Proceedings.

CHAUVEHEID, F., VON FRENCKELL, C., Colin, G., DEFLANDRE, E., DUYSINX, B., Piette, Y., Malaise, M., & MALAISE, O. (December 2020). Traiter un cancer pulmonaire avec une dermatomyosite « paranéoplasique » associée par un inhibiteur des points de contrôle immunitaire : une fausse bonne idée ? Revue du Rhumatisme, 87 (S1), 235-A236. doi:10.1016/j.rhum.2020.10.420

CIREGIA, F., Nys, G., COBRAIVILLE, G., Badot, V., Di Romana, S., Sidiras, P., Sokolova, T., Durez, P., Fillet, M., Malaise, M., & DE SENY, D. (December 2020). Caractérisation de l’expression des alarmines et des variants A-SAA dans la polyarthrite rhumatoïde débutante. Revue du Rhumatisme, 87 (S1), 126. doi:10.1016/j.rhum.2020.10.218

GERARD, C., RINKIN, C., Lamaye, C., SEIDEL, L., HUSTINX, R., Malaise, M., & MALAISE, O. (December 2020). Les recommandations « ostéoporose » SFR 2018 identifient une population de polyarthrites rhumatoïdes avec une activité plus élevée et une micro-architecture osseuse (Hr-pQCT) moins bonne : étude de l’influence de la maladie sur les paramètres osseux. Revue du Rhumatisme, 87 (S1), 226. doi:10.1016/j.rhum.2020.10.400

CHAUVEHEID, F., VON FRENCKELL, C., Colin, G., DEFLANDRE, E., Piette Yves, DUYSINX, B., MALAISE, M., & MALAISE, O. (September 2020). Treating cancer with associated paraneoplastic dermatomyositis with immune checkpoint inhibitor, a false good idea? [Paper presentation]. Belgian congress of rheumatology.

Parzibut, G., GUIOT, J., Misset, B., MALAISE, M., LOUIS, R., LOUIS, E., HENKET, M., MOERMANS, C., & NJOCK, M.-S. (September 2020). Alteration of Plasma Exosome Content in Acute Respiratory Distress Syndrome: a miRNA signature associated to lung fibrosing process [Poster presentation]. ERS International Congress 2020. doi:10.1183/13993003.congress-2020.3828

GUIOT, J., Cambier, M., Boeckx, A., HENKET, M., Nivelles, O., GESTER, F., LOUIS, E., MALAISE, M., Dequiedt, F., LOUIS, R., Struman, I.* , & NJOCK, M.-S.*. (05 August 2020). Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p. Thorax, 75 (10), 870-881. doi:10.1136/thoraxjnl-2019-214077
* These authors have contributed equally to this work.

DE SENY, D., BIANCHI, E., Baiwir, D., COBRAIVILLE, G., Collin, C., Deliège, M., KAISER, M.-J., Mazzucchelli, G., Hauzeur, J.-P., DELVENNE, P., & MALAISE, M. (May 2020). Proteins involved in the endoplasmic reticulum stress are key players in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score [Poster presentation]. OARSI, Vienna, Austria.

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375.

Poulet, C., NJOCK, M.-S., MOERMANS, C., LOUIS, E., LOUIS, R., MALAISE, M., & GUIOT, J. (01 May 2020). Exosomal Long Non-Coding RNAs in Lung Diseases. International Journal of Molecular Sciences, 21 (10), 3580. doi:10.3390/ijms21103580

CHARLIER, E.* , DEROYER, C.* , NEUVILLE, S., Plener, Z., MALAISE, O., Ciregia, F., Gillet, P., Reuter, G., Salvé, M., Withofs, N., Hustinx, R., de Seny, D., & Malaise, M. (2020). Toward diagnostic relevance of the α(V)β(5), α(V)β(3), and α(V)β(6) integrins in OA: expression within human cartilage and spinal osteophytes. Bone Research, 8, 35. doi:10.1038/s41413-020-00110-4
* These authors have contributed equally to this work.

Ciregia, F., Baiwir, D., COBRAIVILLE, G., DEWAEL, T., Mazzucchelli, G., Badot, V., Di Romana, S., Sidiras, P., Sokolova, T., Durez, P., Malaise, M., & de Seny, D. (2020). Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis. Journal of Translational Medicine, 18 (1). doi:10.1186/s12967-019-02188-9

de Seny, D., Bianchi, E., Baiwir, D., COBRAIVILLE, G., Collin, C., Deliège, M., Kaiser, M.-J., Mazzucchelli, G., Hauzeur, J.-P., Delvenne, P., & Malaise, M. (2020). Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score. Scientific Reports, 10 (1). doi:10.1038/s41598-020-70803-7

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., Malaise, M., & MALAISE, O. (2020). Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2020-218244

Guiot, J., HENKET, M., André, B., Herzog, M., Hardat, N., NJOCK, M.-S., MOERMANS, C., Malaise, M., & Louis, R. (2020). A new nucleosomic-based model to identify and diagnose SSc-ILD. Clinical Epigenetics, 12 (1), 124. doi:10.1186/s13148-020-00915-4

HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315.

Malaise, O., Detroz, M., Leroy, M., Leonori, L., SEIDEL, L., & Malaise, M. (2020). High detection rate of osteoporosis with screening of a general hospitalized population: a 6-year study in 6406 patients in a university hospital setting. BMC Musculoskeletal Disorders, 21 (1), 90. doi:10.1186/s12891-020-3116-9

CIREGIA, F., Baiwir, D., COBRAIVILLE, G., DEWAEL, T., Mazzucchelli, G., Badot, V., Di Romana, S., Sidiras, P., Sokolova, T., Durez, P., Malaise, M., & DE SENY, D. (09 December 2019). Le déficit de la N-glycosylation de la corticosteroid–binding globulin et de la lipopolysaccharide–binding protein est associé à l'activité de la maladie et à la réponse au traitement dans la polyarthrite rhumatoïde [Paper presentation]. 32ème Congrès Français de Rhumatologie, Paris, France.

DE SENY, D., BIANCHI, E., Baiwir, D., Mazzucchelli, G., DEROYER, C., CIREGIA, F., MALAISE, O., KAISER, M.-J., Hauzeur, J.-P., DELVENNE, P., & MALAISE, M. (09 December 2019). La protéomique synoviale identifie de nouvelles protéines corrélées au score inflammatoire histologique : comparaison entre arthrose, chondrocalcinose et polyarthrite rhumatöide [Paper presentation]. 32ème Congrès Français de Rhumatologie, Paris, France.

MALAISE, O., André Céline, SCHLEICH, F., LOUIS, R., & MALAISE, M. (November 2019). Systematic Osteoporosis Screening In Chronic Obtructive Pulmonary Disease (Study Of Correlation Between Pulmonary Functions Tests And Bone Parameters): Emphysematous Status Is Linked To Low Bone Density And Osteoporosis [Poster presentation]. American Congress of Rheumatology, 2019.

Nys, G., COBRAIVILLE, G., Servais, A.-C., Malaise, M., DE SENY, D., & Fillet, M. (2019). Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis. Talanta. doi:10.1016/j.talanta.2019.06.044

Mina, M., Horrion Jil, SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., MALAISE, M., & MALAISE, O. (September 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Belgian Congress of Rheumatology.

Vaamonde-Garcia, C., MALAISE, O., CHARLIER, E., DEROYER, C., NEUVILLE, S., GILLET, P., Kurth, W., Meijide-Failde, R., MALAISE, M., & DE SENY, D. (2019). 15-Deoxy-Δ-12, 14-prostaglandin J2 acts cooperatively with prednisolone to reduce TGF-β-induced pro-fibrotic pathways in human osteoarthritis fibroblasts. Biochemical Pharmacology. doi:10.1016/j.bcp.2019.03.039

MALAISE, O., DETROZ, M., LEROY, M., LEONORI, L., SEIDEL, L., & MALAISE, M. (2019). SCREENING FOR OSTEOPOROSIS IN AN AMBULATORY AND HOSPITALIZED POPULATION: A 6- YEAR EXPERIENCE IN A UNIVERSITY HOSPITAL. Annals of the Rheumatic Diseases, 0840. doi:10.1136/annrheumdis-2019-eular.4221

Charlier, E., NEUVILLE, S., PLENER, Z., DEROYER, C., RELIC, B., MALAISE, O., REUTER, G., GILLET, P., Salvé, M., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (May 2019). EXPRESSION OF αVβ5, αVβ3 AND β6 INTEGRINS BY OSTEOARTHRITIC CHONDROCYTES AND VERTEBRAL OSTEOPHYTES [Poster presentation]. OARSI, Toronto, Canada.

DE SENY, D., DEROYER, C., Charlier, E., CIREGIA, F., COBRAIVILLE, G., MEUWIS, M.-A., LOUIS, E., Fillet, M., & MALAISE, M. (May 2019). Increased serological levels of vitronectin(amino acid 381-397) and C3f peptides in osteoarthritis, lupus and scleroderma. Interaction with TGF-β [Poster presentation]. OARSI, Toronto, Canada.

DEROYER, C., Charlier, E., NEUVILLE, S., MALAISE, O., MALAISE, M., & DE SENY, D. (May 2019). CEMIP (KIAA1199) induces a fibrosis-like process in OA chondrocytes [Poster presentation]. OARSI 2019, Toronto, Canada.

Mina, M., Horrion, J., SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., Malaise, M., & MALAISE, O. (March 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Bone Curriculum Symposium 2019.

DEROYER, C., CHARLIER, E., NEUVILLE, S., MALAISE, O., GILLET, P., KURTH, W., Chariot, A., MALAISE, M., & DE SENY, D. (2019). CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes. Cell Death and Disease. doi:10.1038/s41419-019-1377-8

BONHOMME, O., ANDRE, B., GESTER, F., DE SENY, D., MOERMANS, C., Struman, I., Louis, R., MALAISE, M., & GUIOT, J. (2019). Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature. Rheumatology (Oxford, England). doi:10.1093/rheumatology/kez230

Charlier, E., DEROYER, C., Ciregia, F., MALAISE, O., NEUVILLE, S., PLENER, Z., Malaise, M., & de Seny, D. (2019). Chondrocyte dedifferentiation and osteoarthritis (OA). Biochemical Pharmacology, 165, 49-65. doi:10.1016/j.bcp.2019.02.036

GUIOT, J., Struman, I., Louis, E., Louis, R., Malaise, M., & Njock, M.-S. (2019). Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets. Journal of Clinical Medicine, 8 (9). doi:10.3390/jcm8091345

Henrotin, Y., Bannuru, R., Malaise, M., Ea, H.-K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, J.-P., Thomas, P., Hick, A.-C., Marinello, A., Giordan, N., & Richette, P. (2019). Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: Data from MOKHA study. BMC Musculoskeletal Disorders, 20 (1). doi:10.1186/s12891-019-2667-0

Henrotin, Y., Malaise, M., Wittoek, R., De Vlam, K., Brasseur, J.-P., Luyten, F. P., Jiangang, Q., Van Den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., Donneau, A.-F., & Dierckxsens, Y. (2019). Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study. Arthritis Research and Therapy, 21 (1). doi:10.1186/s13075-019-1960-5

MALAISE, O., André, C., SEIDEL, L., SCHLEICH, F., LOUIS, R., & Malaise, M. (2019). Intérêt du dépistage systématique par ostéodensitométrie osseuse chez des patients souffrant de bronchopneumopathie chronique obstructive (BPCO): indice de masse corporel bas, tabagisme actif et phénotype emphysémateux comme principaux facteurs de risque d’ostéoporose. Revue du Rhumatisme.

DE SENY, D., COBRAIVILLE, G., DEROYER, C., MEUWIS, M.-A., LOUIS, E., Fillet, M., & MALAISE, M. (10 December 2018). Elévation des taux sériques des peptides C3f et vitronectine (acide aminés 381-397) dans l’arthrose, le lupus et la sclérodermie. Interaction avec le TGF-β [Poster presentation]. 31ème Congrès Français de Rhumatologie, Paris, France.

DEROYER, C., Charlier, E., Malaise, O., Malaise, M., & DE SENY, D. (10 December 2018). CEMIP accompagne l’expression de marqueurs de fibrose par le cartilage et la synoviale arthrosique [Poster presentation]. 31e congrès français de rhumatologie, Paris, France.

MALAISE, O., Detrooz, M., LEROY, M., LEONORI, L., SEIDEL, L., & MALAISE, M. (2018). Dépistage de l’ostéoporose dans une population ambulatoire et hospitalisée : une expérience de 6 ans au CHU de Liège. Revue du Rhumatisme.

MALAISE, O., Collee, J., SEGHAYE, M.-C., Castermans Caroline, VAN LINTHOUT, C., & MALAISE, M. (September 2018). WHEN BABY’S HEART REVEALS MUM’S DISEASE [Poster presentation]. Belgian Congress of Rheumatology.

MALAISE, O., el Massaoui Majdouline, GERARD, C., JACQUERIE, P., Bonnevie, F., MASSAGE, P., & MALAISE, M. (September 2018). AN UNUSUAL CASE OF TENOSYNOVITIS : CHRONIC INFECTION WITH MYCOBACTERIUM HERAKLIONENSE [Poster presentation]. Belgian Congress of Rheumatology.

Henrotin, Y., Bannuru, R. R., Malaise, M., EA, K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, Thomas, T., Marrinello, A., Giordan, N., & Richette, P. (June 2018). HYALURONAN DERIVATIVE HYMOVIS® INCREASES CARTILAGE VOLUME AND TYPE II COLLAGEN TURNOVER IN OSTEOARHRITIC KNEE: DATA FROM MOKHA STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 1614.

Henrotin, Y., Malaise, M., Wittoek, R., Devlam, K., Brasseur, J.-P., Luyten, F., Jiangang, Q., Van den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., & Dierckxsens, Y. (June 2018). EFFICACY OF BIO-OPTIMISED CURCUMA EXTRACT (FLEXOFYTOL®) FOR PAINFUL KNEE OSTEOARTHRITIS: DATA FROM COPRA, A MULTICENTER RANDOMISED CONTROLLED STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 790.

CHARLIER, E., NEUVILLE, S., RELIC, B., DEROYER, C., MALAISE, O., KURTH, W., GILLET, P., DE SENY, D., & MALAISE, M. (April 2018). Regulation of α5 and β1 integrin expression by osteogenic or adipogenic differentiation as well as by TGFβ in human hip OA chondrocytes [Poster presentation]. 2018 World Congress on Osteoarthritis.

DEROYER, C., Charlier, E., NEUVILLE, S., MALAISE, O., Malaise, M., & DE SENY, D. (2018). CEMIP induces a fibrosis-like process in OA chondrocytes [Poster presentation]. OARSI 2018.

Fosse, P., KAISER, M.-J., Namur, G., DE SENY, D., Malaise, M., & Hustinx, R. (2018). (18)F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab. European Journal of Hybrid Imaging, 2 (1), 6. doi:10.1186/s41824-017-0022-y

HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8

RELIC, B., CHARLIER, A., DEROYER, C., MALAISE, O., Crine, Y., NEUVILLE, S., GILLET, P., DE SENY, D., & Malaise, M. (2018). Serum starvation raises turnover of phosphorylated p62/SQSTM1 (Serine 349), reveals expression of proteasome and N-glycanase1 interactive protein RAD23B and sensitizes human synovial fibroblasts to BAY 11-7085-induced cell death. Oncotarget, 9 (88), 35830-35843. doi:10.18632/oncotarget.26295

CHARLIER, E., NEUVILLE, S., RELIC, B., DEROYER, C., MALAISE, O., KURTH, W., GILLET, P., DE SENY, D., & MALAISE, M. (10 December 2017). Régulation de l’expression des intégrines a5 et ß1 par la différenciation ostéogénique ou adipogénique ainsi que par le TGFß dans les chondrocytes humains arthrosiques de hanche [Paper presentation]. 30ème Congrès Français de Rhumatologie.

DE SENY, D., Baiwir, D., Collin, C., Deliège, M., DELVENNE, P., De Pauw, E., Hauzeur, J.-P., & MALAISE, M. (10 December 2017). Analyse protéomique de biopsies synoviales: comparaison entre arthrose, arthrose avec chondrocalcinose et polyarthrite rhumatoïde [Paper presentation]. 30ème Congrès Français de Rhumatologie, Paris, France.

DEROYER, C., Charlier, E., Malaise, O., MALAISE, M., & DE SENY, D. (10 December 2017). Rôle de KIAA1199 dans le développement de l’arthrose [Paper presentation]. 30e congrès français de rhumatologie, Paris, France.

Rinkin, C., Fosse, P., Hustinx, R., & Malaise, M. (November 2017). Tomographie à émission de positons par 18F-fluorodeoxyglucose dans la polyarthrite rhumatoïde : corrélation avec les scores cliniques d’activité. Revue du Rhumatisme, 84 (S1), 211.

DEROYER, C., NEUVILLE, S., Charlier, E., MALAISE, O., MALAISE, M., & DE SENY, D. (28 April 2017). Role of KIAA1199 in osteoarthritic cartilage degradation [Poster presentation]. OARSI 2017.

CHARLIER, E., NEUVILLE, S., RELIC, B., DEROYER, C., MALAISE, O., KURTH, W., GILLET, P., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (April 2017). Regulation of αVβ3 and αVβ5 integrin complexes by osteogenic differentiation of human hip OA chondrocytes [Poster presentation]. 2017 World Congress on Osteoarthritis.

QUESADA-CALVO, F., MASSOT, C., Bertrand, V., Longuespée, R., BLETARD, N., SOMJA, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw-Gillet, M.-C., Delvenne, P., MALAISE, M., COIMBRA MARQUES, C., POLUS, M., De Pauw, E., MEUWIS, M.-A., & Louis, E. (24 March 2017). OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages. Clinical Proteomics, 24 (9). doi:10.1186/s12014-017-9143-3

QUESADA-CALVO, F., Merli, A.-M., MASSOT, C., BLETARD, N., SOMJA, J., Smargiasso, N., Baiwir, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., COIMBRA MARQUES, C., POLUS, M., MALAISE, M., De Pauw, E., DELVENNE, P., MEUWIS, M.-A., & LOUIS, E. (10 February 2017). Proteomic differential distribution of 53BP1 in serrated and conventional adenomas validated by histological characterisation [Poster presentation]. Belgian week of Gastroenterology, Anvers, Belgium.

Merli, A.-M., QUESADA-CALVO, F., MASSOT, C., BLETARD, N., Smargiasso, N., Baiwir, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., MALAISE, M., De Pauw, E., DELVENNE, P., Meuwis, M.-A., & Louis, E. (09 February 2017). Identification of proteins discriminating inflammation induced dysplasia from simple inflammation in ulcerative colitis by laser capture microdissection and label free proteomics – a pilot study [Paper presentation]. XXIXth edition of the Belgian Week of Gastroenterology, Anvers, Belgium.

Merli, A.-M., QUESADA-CALVO, F., MASSOT, C., BLETARD, N., Smargiasso, N., Baiwir, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., MALAISE, M., De Pauw, E., DELVENNE, P., Meuwis, M.-A., & Louis, E. (01 February 2017). Identification of proteins discriminating inflammation induced dysplasia from simple inflammation in ulcerative colitis by laser capture microdissection and label free proteomics – a pilot study [Poster presentation]. GIGA DAY 2017, Liège, Belgium.

COBRAIVILLE, G., Fillet, M., Sharif, M., Ourradi, K., Nys, G., Malaise, M., & DE SENY, D. (2017). Validation of a new method by nano-liquid chromatography on chip tandem mass spectrometry for combined quantitation of C3f and the V65 vitronectin fragment as biomarkers of diagnosis and severity of osteoarthritis. Talanta, 169, 170-180. doi:10.1016/j.talanta.2017.03.078

CHARLIER, E., RELIC, B., Deroyer, C., MALAISE, O., NEUVILLE, S., Collée, J., MALAISE, M., & DE SENY, D. (2016). Insights on Molecular Mechanisms of Chondrocytes Death in Osteoarthritis. International Journal of Molecular Sciences. doi:10.3390/ijms17122146

HAUZEUR, J.-P., Tungouz, M., LECHANTEUR, C., Beguin, Y., BAUDOUX, E., de maertelaer, V., Pather, S., Katz, R., Ino, J., Egrise, D., Malaise, M., & Gangji, V. (October 2016). Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée. Revue de Chirurgie Orthopédique et Traumatologie, 102, 73. doi:10.1016/j.rcot.2016.08.002

DE SENY, D., COBRAIVILLE, G., Leprince, P., Fillet, M., Collin, C., Mathieu, M., HAUZEUR, J.-P., Gangji, V., & Malaise, M. (2016). Biomarkers of inflammation and innate immunity in atrophic nonunion fracture. Journal of Translational Medicine. doi:10.1186/s12967-016-1019-1

RELIC, B., CHARLIER, E., Deroyer, C., MALAISE, O., NEUVILLE, S., Desoroux A, Gillet, P., DE SENY, D., & Malaise, M. (26 April 2016). BAY 11-7085 induces glucocorticoid receptor activation and autophagy that collaborate with apoptosis to induce human synovial fibroblast cell death. Oncotarget, 7 (17), 23370-82. doi:10.18632/oncotarget.8042

Charlier, E., DEROYER, C., MALAISE, O., NEUVILLE, S., COBRAIVILLE, G., GILLET, P., KURTH, W., DE SENY, D., & MALAISE, M. (01 April 2016). Insights into the role of Dickkopf 3 (Dkk3) on Wnt/β-catenin and TGFβ ALK1/Smad1/5 signaling pathways as well as on leptin production during human hip OA chondrocytes dedifferentiation [Poster presentation]. OARSI 2016.

CHARLIER, E., MALAISE, O., Deroyer, C., Zeddou, M., NEUVILLE, S., COBRAIVILLE, G., Gillet, P., KURTH, W., De Seny, D., RELIC, B., & Malaise, M. (April 2016). Dickkopf 3 (Dkk3) is increased along human hip OA chondrocytes dedifferentiation and can modulate Wnt/Β-catenin and TGFβ Alk1/Smad1/5 signaling pathways, as well as leptin production [Poster presentation]. OARSI 2016 world congress.

QUESADA-CALVO, F., Meuwis, M.-A., Bertrand, V., Longuespée, R., BLETARD, N., SOMJA, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw-Gillet, M.-C., Delvenne, P., Malaise, M., COIMBRA MARQUES, C., POLUS, M., De Pauw, E., & Louis, E. (19 February 2016). Proteins in early CRC stages - from proteomic discovery to immunohistochemistry tissue distribution characterisation [Poster presentation]. Belgian Week of Gastroenterology, Bruxelles, Belgium.

HAUZEUR, J.-P., Malaise, M., & de MARTELAER, V. (2016). A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis. International Orthopaedics. doi:10.1007/s00264-015-3079-x

CHARLIER, E.* , MALAISE, O.* , Zeddou, M., NEUVILLE, S., COBRAIVILLE, G., DEROYER, C., Sanchez, C., Gillet, P., KURTH, W., DE SENY, D., RELIC, B., & MALAISE, M. (2016). Restriction of spontaneous and prednisolone-induced leptin production to dedifferentiated state in human hip OA chondrocytes: role of Smad1 and b-catenin activation. Osteoarthritis and Cartilage. doi:10.1016/j.joca.2015.08.002
* These authors have contributed equally to this work.

MALAISE, O., RELIC, B., Charlier, E., Zeddou, M., NEUVILLE, S., Deroyer, C., Gillet, P., Louis, E., Malaise, M., & DE SENY, D. (2016). Glucocorticoid-induced leucine zipper (GILZ) is involved in glucocorticoid-induced and mineralocorticoid-induced leptin production by osteoarthritis synovial fibroblasts. Arthritis Research and Therapy, 18 (1), 219. doi:10.1186/s13075-016-1119-6

Baiwir, D., Mazzucchelli, G., Smargiasso, N., QUESADA CALVO, F., De Pauw, E., MALAISE, M., Louis, E., & MEUWIS, M.-A. (December 2015). Comparison of serum fractionation methods by data independent label-free proteomics. EuPA Open Proteomics, 9, 14-22. doi:10.1016/j.euprot.2015.07.009

QUESADA-CALVO, F., Meuwis, M.-A., Bertrand, V., Longuespée, R., BLETARD, N., Somja, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw-Gillet, M.-C., Delvenne, P., Malaise, M., POLUS, M., De Pauw, E., & Louis, E. (27 October 2015). LABEL FREE PROTEOMICS IDENTIFIES OLFACTOMEDIN-4 AS A MARKER OF EPITHELIAL TRANSITION OF EARLY CRC STAGES [Paper presentation]. UEG Week Barcelona 2015, Barcelona, Spain.

MALAISE, O., CHAUVEHEID, F., VON FRENCKELL, C., LEONARD, P., MOUTSCHEN, M., DEMONTY, J., & MALAISE, M. (September 2015). Newly diagnosed adult onset Still’s disease between 2002 and 2014: retrospective clinical biological and therapeutic characterization. Comparison with 1988 – 2001 data [Poster presentation]. Belgian congress of Rheumatology 2015.

MALAISE, O., DENEYE, M., BETEA, D., RACARU, T., KURTH, W., DEGIVES, R., & Malaise, M. (September 2015). Langerhans cell histiocytosis with multifocal bone lesions: complete metabolic remission by methotrexate and a local glucocorticoid injection [Paper presentation]. Congrès de la Société Belge de Rhumatologie.

MALAISE, O., GESTER, F., Thonnard Anne-Sophie, Marchetta Stella, VON FRENCKELL, C., & MALAISE, M. (September 2015). Pericarditis revealing an anti-Jo-1 anti-synthetase syndrome in an elderly patient [Poster presentation]. Belgian congress of rheumatology 2015.

SIMONI, P., Gerard, L., KAISER, M.-J., RIBBENS, C., RINKIN, C., MALAISE, O., & Malaise, M. (2015). Use of Tomosynthesis for Detection of Bone Erosions of the Foot in Patients With Established Rheumatoid Arthritis: Comparison With Radiography and CT. American Journal of Roentgenology, (205), 364-370. doi:10.2214/AJR.14.14120

DE SENY, D., COBRAIVILLE, G., CHARLIER, E., NEUVILLE, S., LUTTERI, L., LE GOFF, C., MALAISE, D., MALAISE, O., CHAPELLE, J.-P., RELIC, B., & MALAISE, M. (2015). Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties. PLoS ONE. doi:10.1371/journal.pone.0122904

QUESADA CALVO, F., MEUWIS, M.-A., Bertrand, V., Longuespée, R., SOMJA, J., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Delvenne, P., MALAISE, M., POLUS, M., De Pauw-Gillet, M.-C., De Pauw, E., & Louis, E. (2015). Comparison of early stages of colorectal cancer by label free proteomics. In Acta Gastroenterologica.

MEUWIS, M.-A., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Smargiasso, N., De Pauw, E., MALAISE, M., GETAID, & LOUIS, E. (2015). Potential Proteomic Biomarkers Associated with Mucosal Healing and Relapse Prediction after IFX Withdrawals in Crohn’s Disease. In Acta gastroenterologica.

MALAISE, O., RELIC, B., QUESADA CALVO, F., Charlier, E., Zeddou, M., NEUVILLE, S., Gillet, P., Louis, E., DE SENY, D., & MALAISE, M. (2015). Selective glucocorticoid receptor modulator compound A, in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts. Rheumatology. doi:10.1093/rheumatology/keu428

WITHOFS, N., CHARLIER, E., Simoni, P., Alvarez-Miezentseva, V., Mievis, F., Giacomelli, F., Mella, C., Gambhir, S. S., Malaise, O., DE SENY, D., MALAISE, M., & HUSTINX, R. (2015). (18)F-FPRGD2 PET/CT imaging of musculoskeletal disorders. Annals of Nuclear Medicine, 29 (10), 839-47. doi:10.1007/s12149-015-1011-5

MALAISE, O., RELIC, B., NEUVILLE, S., CHARLIER, E., DE SENY, D., & MALAISE, M. (08 December 2014). GILZ (Glucocorticoid-Induced Leuzine Zipper) est un intermédiaire de l’action des corticoïdes sur les cellules arthrosiques : implication dans la sécrétion de leptine et l’expression de son récepteur, mais pas dans les effets anti-inflammatoires [Paper presentation]. Congrès de la Société Française de Rhumatologie.

MALAISE, O., JACQUERIE, P., Halleux, S., LUTTERI, L., VON FRENCKELL, C., & Malaise, M. (December 2014). Co-existence des anticorps anti-ADN double brin et des anticorps anti-peptides citrullinés: entre lupus médicamenteux induit et rhupus [Poster presentation]. Congrès de la Société Française de Rhumatologie 2014.

MUTIJIMA NZARAMBA, E., De Maertelaer, V., Deprez, M., Malaise, M., & HAUZEUR, J.-P. (December 2014). The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution. Clinical Rheumatology, 33 (12), 1791-5. doi:10.1007/s10067-014-2607-1

ZEDDOU M, RELIC, B., & Malaise, M. (2014). Umbilical cord fibroblasts. Rheumatology.

MEUWIS, M.-A., Baiwir, D., Mazzucchelli, G., Smargiasso, N., Quesada-Calvo, F., MALAISE, M., De Pauw, E., The GETAID, & LOUIS, E. (06 October 2014). Potential Proteomic Biomarkers Associated To Mucosal Healing In Crohn’s Disease [Poster presentation]. HUPO2014, Madrid, Spain.

MALAISE, O., RELIC, B., NEUVILLE, S., CHARLIER, E., DE SENY, D., & Malaise, M. (24 September 2014). Leptin production by osteoarthritic synovial fibroblasts [Paper presentation]. Congrès de la Société Belge de Rhumatologie.

MALAISE, O., RELIC, B., NEUVILLE, S., Charlier, E., DE SENY, D., & MALAISE, M. (September 2014). Leptin production by osteoarthritis synovial fibroblasts: stimulation by glucocorticoids and mineralocorticoids through the glucocorticoid receptor and GILZ (Glucocorticoid-Induced Leucine Zipper) protein [Paper presentation]. Belgian Congress of Rheumatology, 2014.

De Bock, M., BEGUIN, Y., Leprince, P., WILLEMS, E., BARON, F., Deroyer, C., Seidel, L., CAVALIER, E., DE SENY, D., MALAISE, M., GOTHOT, A., MERVILLE, M.-P., & Fillet, M. (July 2014). Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers. Talanta, 125, 265-275. doi:10.1016/j.talanta.2014.03.017

MALAISE, O., LIBON, F., BRICMAAN J, VON FRENCKELL, C., SIMONI, P., LEONARD P, & Malaise, M. (22 January 2014). Two spondylodiscitis due to a contamination by Brucella melitensis in a mother and daughter back from holidays. Revue Médicale de la Suisse Romande, 10 (404), 197-200.

MALAISE, O., RELIC, B., NEUVILLE, S., CHARLIER, E., DE SENY, D., & Malaise, M. (2014). The glucocorticoid-induced leucine zipper (GILZ) is involved in corticosteroid-induced leptin production by human osteoarthritis synovial fibroblasts in vitro. Osteoarthritis and Cartilage, 22, 449-450.

MALAISE, O., RELIC, B., NEUVILLE, S., CHARLIER, E., DE SENY, D., & MALAISE, M. (2014). Leptin Production By Osteoarthritis Synovial Fibroblasts: Stimulation By Glucocorticoids and Mineralocorticoids through the Glucocorticoid Receptor and GILZ (Glucocorticoid-Induced Leucine Zipper) Protein. Arthritis and Rheumatism, 66 (11), 454.

QUESADA CALVO, F., Bertrand, V., Longuespée, R., Delga, A., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Delvenne, P., MALAISE, M., De Pauw-Gillet, M.-C., De Pauw, E., Louis, E., & Meuwis, M.-A. (2014). Comparison of two FFPE preparation methods using label-free shotgun proteomics: Application to tissues of diverticulitis patients. Journal of Proteomics, 112C, 250-261. doi:10.1016/j.jprot.2014.08.013

MALAISE, O., VON FRENCKELL, C., ANDRE, B., & Malaise, M. (28 August 2013). The management of systemic lupus erythematosus with biological therapies. Revue Médicale Suisse, 9 (395), 1507-11.

MALAISE, O., VON FRENCKELL, C., ANDRE, B., & MALAISE, M. (August 2013). The management of systemic lupus erythematosus with biological therapies. Revue Médicale de Liège, 28 (9(395)), 1507-11.

RINKIN, C., VAN DURME, C., FAUTREL, B., & Malaise, M. (July 2013). Un cas rare d’arthrite fébrile. Revue Médicale de Liège, 68 (7-8), 423-7.

DE SENY, D., COBRAIVILLE, G., CHARLIER, E., NEUVILLE, S., Esser, N., MALAISE, D., MALAISE, O., Calvo, F., RELIC, B., & MALAISE, M. (2013). Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties. PLoS ONE. doi:10.1371/journal.pone.0066769

Hauzeur, J.-P., Bernard, C., Egrise, D., Kurth, W., Van Cauwenberge, H., LECHANTEUR, C., Gillet, P., Beguin, Y., MALAISE, M., & HUSTINX, R. (2013). (111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures. International Orthopaedics, 37 (1), 131-6. doi:10.1007/s00264-012-1719-y

MALAISE, O., RELIC, B., CHARLIER, E., Zeddou, M., QUESADA-CALVO, F., NEUVILLE, S., DE SENY, D., & Malaise, M. (2013). Glucocorticoid receptor modulator Compound A does not induce leptin in human osteoarthritic synovial fibroblasts and in dedifferentiated chondrocytes. Arthritis and Rheumatism, 65 (10), 55.

MALAISE, O., RELIC, B., CHARLIER, E., zeddou, M., QUESADA-CALVO, F., NEUVILLE, S., DE SENY, D., & MALAISE, M. (2013). Compound A, un modulateur du récepteur aux glucocorticoïdes, ne stimule la production de leptine ni chez les fibroblastes synoviaux humains d’origine arthrosique, ni chez les chondrocytes dédifférenciés humains. Revue du Rhumatisme, 80 (1), 352.

MALAISE, O., HALLEUX, S., VON FRENCKELL, C., LUTTERI, L., CHAPELLE, J.-P., & Malaise, M. (September 2012). Rhupus: when rheumatoid arthritis meets lupus. Revue Médicale de Liège, 67 (9), 475-84.

MALAISE, O., VON FRENCKELL, C., & Malaise, M. (May 2012). Genetic and environmental interactions on the development of rheumatoid arthritis. Revue Médicale de Liège, 67 (5-6), 305-13.

MALAISE, O., MALAISE, M., & Simoni, P. (April 2012). L'image du mois. Goutte tophacée floride de l'avant-pied. Revue Médicale de Liège, 67 (4), 165-6.

MALAISE, O.* , RELIC, B.* , CHARLIER, E., Zeddou, M., QUESADA-CALVO, F., NEUVILLE, S., DE SENY, D., & MALAISE, M. (2012). Les minéralocorticoïdes (aldostérone) stimulent la production de leptine des fibroblastes synoviaux d'origine arthrosique : implication du récepteur aux glucocorticoïdes, mais pas du récepteur aux minéralocorticoïdes. Revue du Rhumatisme, 79, 352.
* These authors have contributed equally to this work.

MALAISE, O., RELIC, B., CHARLIER, E., Zeddou, M., QUESADA-CALVO, F., NEUVILLE, S., DE SENY, D., & MALAISE, M. (2012). Human chondrocyte dedifferentiation is accompagnied by CD105 endoglin expression, ALK-1/Smad1/5 phosphorylation and leptin production – Stimulation by prednisolone and aldosterone through the glucocorticoid receptor. Arthritis and Rheumatism, 64 (10), 50.

MALAISE, O., VON FRENCKELL, C., & MALAISE, M. (2012). Interactions de la génétique et de l’environnement sur le développement de la polyarthrite rhumatoïde. Revue Médicale de Liège, 67 (5-6), 305-313.

VON FRENCKELL, C., & Malaise, M. (2012). Targeted therapy in inflammatory disease: cytokines. Revue Médicale de Liège, 67 (22-8).

Zeddou, M., RELIC, B., MALAISE, O., CHARLIER, E., Desouroux, A., BEGUIN, Y., DE SENY, D., & Malaise, M. (2012). Differential signalling through ALK-1 and ALK-5 regulates leptin expression in Mesenchymal Stem Cells. Stem Cells and Development, 21 (11), 1948-54. doi:10.1089/scd.2011.0321

Dooley, M. A., Jayne, D., Ginzler, E. M., Isenberg, D., & Malaise, M. (Other coll.). (November 2011). Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. New England Journal of Medicine, 365 (20), 1886-1895. doi:10.1056/NEJMoa1014460

Klareskog, L., Gaubitz, M., Rodriguez-Valverde, V., Malaise, M., Dougados, M., Wajdula, J., & Etanercept Study 301 Investigators. (2011). Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2011 Mar-Apr, 238-247.

BERNARD, C., HAUZEUR, J.-P., LECHANTEUR, C., VAN CAUWENBERGE, H., BEGUIN, Y., MALAISE, M., KURTH, W., GILLET, P., & HUSTINX, R. (2011). Evaluation of the homing process in the treatment of atrophic nonunion fractures by percutaneous autologous osteoblast cell implantation. Journal of Nuclear Medicine, 52 (SUPPL), 510.

DE SENY, D., Sharif, M., Fillet, M., COBRAIVILLE, G., Meuwis, M.-A., Marée, R., HAUZEUR, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., Kirwan, J., Ribbens, C., & Malaise, M. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Annals of the Rheumatic Diseases, 70 (6), 1144-52. doi:10.1136/ard.2010.135541

Vander Cruyssen, B., Durez, P., Westhovens, R., KAISER, M.-J., Hoffman, I., De Keyser, F., MIRA Study Group, & Malaise, M. (Other coll.). (10 September 2010). The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues of the optimization of rituximab treatment strategies. Arthritis Research and Therapy, 12 (5), 169. doi:10.1186/ar3129

Conaghan, P. G., D'Agostino, M. A., Le Bars, M., Baron, G., Schmidely, N., Wakefield, R., Ravaud, P., Grassi, W., Martin-Mola, E., So, A., Backhaus, M., Malaise, M., Emery, P., & Dougados, M. (2010). Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Annals of the Rheumatic Diseases, 69, 644–647. doi:10.1136/ard.2008.099564

De Bock, M., De Seny, D., Meuwis, M.-A., Servais, A.-C., Minh, T. Q., Closset, J., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2010). Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis. Talanta, 82, 245-254. doi:10.1016/j.talanta.2010.04.029

FOSSE, P., KAISER, M.-J., NAMUR, G., Malaise, M., & HUSTINX, R. (2010). Assessment of early therapeutic response in anti-TNFα refractory rheumatoid arthritis with FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 37 (SUPPL), 211.

Ginzler, E. M., Wofsy, D., Isenberg, D., Gordon, C., Lisk, L., Malaise, M., & Dooley, M.-A. (2010). Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Arthritis and Rheumatism, 62 (1), 211-221. doi:10.1002/art.25052

Malaise, M. (2010). Editorial "Synthèse 2010" : De la technique pour la clinique. Revue Médicale de Liège, (65), 1-2.

Zeddou, M., Briquet, A., Relic, B., Josse, C., Malaise, M., Gothot, A., Lechanteur, C., & Beguin, Y. (2010). The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biology International, 34 (7), 693-701. doi:10.1042/CBI20090414

Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sanchez-Guerrero, J., Solomons, N., Malaise, M., & Wofsy, D. (2009). Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. Clinical Journal of the American Society of Nephrology, 20 (5), 1103-1112. doi:10.1681/ASN.2008101028

De Bock, M., De Seny, D., Meuwis, M.-A., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2009). Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/906082

De Seny, D., Ribbens, C., Cobraiville, G., Meuwis, M.-A., Marée, R., Geurts, P., Wehenkel, L., Louis, E., Merville, M.-P., Fillet, M., & Malaise, M. (2009). Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt. Revue Médicale de Liège, 64 (Spec No), 29-35.

Hauzeur, J.-P., Malaise, M., & Gangji, V. (2009). Osteonecrosis in inflammatory bowel diseases: a review of the literature. Acta Gastro-Enterologica Belgica, 72 (3), 327-334.

Kaiser, M.-J., Hauzeur, J.-P., Blacher, S., Foidart, J.-M., Deprez, M., Rossknecht, A., & Malaise, M. (2009). Contrast-enhanced coded phase-inversion harmonic sonography of knee synovitis correlates with histological vessel density: 2 automated digital quantifications. Journal of Rheumatology, 36 (7), 1391-400. doi:10.3899/jrheum.080584

Malaise, M. (2009). Synthèse 2009: forger l'avenir. Revue Médicale de Liège, 64 (Spec No), 1.

Relic, B., Zeddou, M., Desoroux, A., Beguin, Y., De Seny, D., & Malaise, M. (2009). Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Laboratory Investigation, 89 (7), 811-822. doi:10.1038/labinvest.2009.41

van der Heijde, D., Burmester, G., Melo-Gomes, J., Codreanu, C., Martin Mola, E., Pedersen, R., Robertson, D., Chang, D., Koenig, A., Malaise, M., & Freundlich, B. (2009). Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. Annals of the Rheumatic Diseases, 68 (7), 1113-1118. doi:10.1136/ard.2008.094375

Von Frenckell, C., & Malaise, M. (2009). Les traitements biologiques en rhumatologie. Revue Médicale de Liège, 64 (5-6), 293-300.

De Seny, D., Fillet, M., Ribbens, C., Marée, R., Meuwis, M.-A., Lutteri, L., Chapelle, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., & Malaise, M. (2008). Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clinical Chemistry, 54, 1066-1075. doi:10.1373/clinchem.2007.099549

Meuwis, M.-A., Fillet, M., Chapelle, J.-P., Malaise, M., Louis, E., & Merville, M.-P. (2008). New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools. Expert Review of Molecular Diagnostics, 8, 327-37. doi:10.1586/14737159.8.3.327

Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P., & Louis, E. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021
* These authors have contributed equally to this work.

NAMUR, G., KAISER, M.-J., Deprez, M., MALAISE, M., & HUSTINX, R. (2008). Is FDG-PET/CT an early indicator of the clinical response to rituximab in rheumatoid arthritis ? Journal of Nuclear Medicine, 49 (SUPPL), 10.

Reenaers, C., Franchimont, N., Oury, C., Belaiche, J., Malaise, M., Bours, V., Theatre, E., Delvenne, P., & Louis, E. (2008). Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease. Scandinavian Journal of Gastroenterology, 43, 1334-1345. doi:10.1080/00365520802200010

Lambert, C., Oury, C., Dejardin, E., Chariot, A., Piette, J., Malaise, M., Merville, M.-P., & Franchimont, N. (September 2007). Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells. Journal of Bone and Mineral Research, 22 (9), 1350-1361. doi:10.1359/jbmr.070508

Burmester, G. R., Mariette, X., Montecucco, C., Monteagudo-Saez, I., Malaise, M., Tzioufas, A. G., Bijlsma, J. W. J., Unnebrink, K., Kary, S., & Kupper, H. (June 2007). Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Annals of the Rheumatic Diseases, 66 (6), 732-739. doi:10.1136/ard.2006.066761

Leclercq, P., Loly, C., Giot, J.-B., Frippiat, F., Medart, L., & Malaise, M. (2007). Spondylodiscite compliquée d'un abcès du psoas. Revue Médicale Suisse, 3 (101), 620-621.

Lutteri, L., Malaise, M., & Chapelle, J.-P. (2007). Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clinica Chimica Acta, 386 (1-2), 76-81. doi:10.1016/j.cca.2007.08.002

Luyten, F. P., Geusens, P., Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., Vander Mijnsbrugge, D., Mathy, L., Hauzeur, J.-P., De Keyser, F., & Van den Bosch, F. (January 2007). A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Annals of the Rheumatic Diseases, 66 (1), 99-106. doi:10.1136/ard.2006.052308

Meuwis, M.-A.* , Fillet, M.* , Geurts, P., De Seny, D., Lutteri, L., Chapelle, J.-P., Bours, V., Wehenkel, L., Belaiche, J., Malaise, M., Louis, E., & Merville, M.-P. (2007). Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology, 73 (9), 1422-1433. doi:10.1016/j.bcp.2006.12.019
* These authors have contributed equally to this work.

Von Frenckell, C., Henno, A., de LA BRASSINNE, M., & Malaise, M. (2007). Le traitement biologique des maladies inflammatoires à médiation immune. Le cas de la dermatologie et de la rhumatologie. Revue Médicale de Liège, 62 (Spec No), 55-62.

Klareskog, L., Gaubitz, M., Rodriguez-Valverde, V., Malaise, M., Dougados, M., & Wajdula, J. (December 2006). A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases, 65 (12), 1578-1584. doi:10.1136/ard.2005.038349

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (May 2006). Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Molecular Pharmacology, 69 (5), 1615-1623. doi:10.1124/mol.105.020479

Beckers, C., Jeukens, X., Ribbens, C., Andre, B., Marcelis, S., Leclercq, P., Kaiser, M.-J., Willems, J., Hustinx, R., & Malaise, M. (March 2006). F-18-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. European Journal of Nuclear Medicine and Molecular Imaging, 33 (3), 275-280. doi:10.1007/s00259-005-1952-3

Cruyssen, B. V., Van Looy, S., Wyns, B., Westhovens, R., Durez, P., Van den Bosch, F., Mielants, H., De Clerck, L., Peretz, A., Malaise, M., Verbruggen, L., Vastesaeger, N., Geldhof, A., Boullart, L., & De Keyser, F. (2006). Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity. Arthritis Research and Therapy, 8 (4), 112. doi:10.1186/ar2001

Henno, A., Rausin, A., Malaise, M., & De La Brassinne, M. (2006). Psoriasis et arthrite psoriasique. Revue Médicale de Liège, 61 (5-6, May-Jun), 334-340.

Hustinx, R., & Malaise, M. (2006). PET imaging of arthritis. PET Clinics, 1, 131-139. doi:10.1016/j.cpet.2006.02.003

Relic, B., Benoit, V., Franchimont, N., Kaiser, M.-J., Hauzeur, J.-P., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2006). Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. Journal of Biological Chemistry, 281 (32), 597-604. doi:10.1074/jbc.M512807200

D'Agostino, M. A., Conaghan, P., Le Bars, M., Baron, G., Grassi, W., Martin-Mola, E., Wakefield, R., Brasseur, J. L., So, A., Backhaus, M., Malaise, M., Burmester, G., Schmidely, N., Ravaud, P., Dougados, M., & Emery, P. (December 2005). EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis. Annals of the Rheumatic Diseases, 64 (12), 1703-1709. doi:10.1136/ard.2005.037994

Westhovens, R., Boonen, A., Verbruggen, L., Durez, P., De Clerck, L., Malaise, M., & Mielants, H. (December 2005). Healthcare consumption and direct costs of rheumatoid arthritis in Belgium. Clinical Rheumatology, 24 (6), 615-619. doi:10.1007/s10067-005-1119-4

Franchimont, N., Wertz, S., & Malaise, M. (November 2005). Interleukin-6: An osteotropic factor influencing bone formation? BONE, 37 (5), 601-606. doi:10.1016/j.bone.2005.06.002

Lutteri, L., Malaise, M., & Chapelle, J.-P. (27 October 2005). Evaluation of the new Elisa CCp assay on unicap 100 [Poster presentation]. Annual Symposium of the Belgian Societies of Clinical Chemistry and Clinical Biology, Liège, Belgium.

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (September 2005). SERMs-induced myeloma cell apoptosis: A study of NF-kappa B inhibition and gene expression signature. Journal of Bone and Mineral Research, 20 (9, Suppl. 1), 213.

Durez, P., Van den Bosch, F., Corluy, L., Veys, E. M., De Clerck, L., Peretz, A., Malaise, M., Devogelaer, J. P., Vastesaeger, N., Geldhof, A., & Westhovens, R. (April 2005). A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study. Rheumatology, 44 (4), 465-468. doi:10.1093/rheumatology/keh494

BECKERS, C., BERNARD, C., KAISER, M.-J., RIBBENS, C., MALAISE, M., & HUSTINX, R. (2005). Time-course study of (F-18)-FDG uptake in psoriatic synovitis. Journal of Nuclear Medicine, 46 (SUPPL), 183.

Conaghan, P., D'Agostino, M. A., Ravaud, P., Baron, G., Le Bars, M., Grassi, W., Martin-Mola, E., Wakefield, R., Brasseur, J.-L., So, A., Backhaus, M., Malaise, M., Burmester, G., Schmidely, N., Emery, P., & Dougados, M. (2005). EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utility. Annals of the Rheumatic Diseases, 64 (12), 1710-1714. doi:10.1136/ard.2005.038026

Cruyssen, B. V., Van Looy, S., Wyns, B., Westhovens, R., Durez, P., Malaise, M., Verbruggen, L., Vastesaeger, N., Geldhof, A., Boullart, L., & De Keyser, F. (2005). DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Research and Therapy, 7 (5), 1063-R1071. doi:10.1186/ar1787

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607
* These authors have contributed equally to this work.

Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relic, B., Chariot, A., Bours, V., Piette, J., Merville, M.-P., & Malaise, M. (2005). Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism, 52 (1), 84-93. doi:10.1002/art.20727

Geurts, P., Fillet, M., De Seny, D., Meuwis, M.-A., Malaise, M., Merville, M.-P., & Wehenkel, L. (2005). Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics, 21 (14), 3138-45. doi:10.1093/bioinformatics/bti494

Jajic, Z., Malaise, M., Nekam, K., Koó, E., Dankó, K., Kovacs, M., & Scarpignato, C. (2005). Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 2³3 (6), 809-818.

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (2005). Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene. Biochemical Pharmacology, 69 (6), 891-901. doi:10.1016/j.bcp.2004.11.030

Franchimont, N., Reenaers, C., Lambert, C., Belaiche, J., Bours, V., Malaise, M., Delvenne, P., & Louis, E. (December 2004). Increased expression of receptor activator of NF-kappa B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clinical and Experimental Immunology, 138 (3), 491-498. doi:10.1111/j.1365-2249.2004.02643.x

Lutteri, L., Malaise, M., & Chapelle, J.-P. (09 October 2004). In rheumatoid arthritis, anti-citrullinated peptides antibodies are concentrated in synovial fluid [Poster presentation]. Symposium de la Société Belge de Biologie Clinique, Belgium.

Franchimont, N., Putzeys, V., Collette, J., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Franchimont, D., Fiasse, R., Pelckmans, P., Malaise, M., Belaiche, J., & Louis, E. (15 September 2004). Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Alimentary Pharmacology and Therapeutics, 20 (6), 607-614. doi:10.1111/j.1365-2036.2004.02152.x

De Seny, D., Fillet, M., Meuwis, M.-A., Lutteri, L., Geurts, P., Wehenkel, L., Bours, V., Piette, J., Malaise, M., & Merville, M.-P. (September 2004). Discovery of new rheumatoid arthritis biomarkers using SELDI-TOF-MS ProteinChip approach. Arthritis and Rheumatism, 50 (9, Suppl. S), 124.

Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964.

Kirwan, J. R., Hallgren, R., Mielants, H., Wollheim, F., Bjorck, E., Persson, T., Book, C., Bowman, S., Byron, M., Cox, N., Field, M., Kanerud, L., Leirisalo-Repo, M., Malaise, M., Mohammad, A., Palmer, R., Petersson, I. F., Ringertz, B., Sheldon, P., ... Van den Bosch, F. (June 2004). A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis. Annals of the Rheumatic Diseases, 63 (6), 688-695. doi:10.1136/ard.2003.008573

van de Putte, B. A., Atkins, C., Malaise, M., Sany, J., Russell, A. S., van Riel, P. L. C. M., Settas, L., Biljsma, J. W., Todesco, S., Dougados, M., Nash, P., Emery, P., Walter, N., Kaul, M., Fischkoff, S., & Kupper, H. (01 May 2004). Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Annals of the Rheumatic Diseases, 63 (5), 508-516. doi:10.1136/ard.2003.013052

Uebelhart, D., Malaise, M., Marcolongo, R., DeVathaire, F., Piperno, M., Mailleux, E., Fioravanti, A., Matoso, L., & Vignon, E. (April 2004). Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis and Cartilage, 12 (4), 269-276. doi:10.1016/j.joca.2004.01.004

Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., Wajdula, J., Pedersen, R., Fatenejad, S., & Sanda, M. (28 February 2004). Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet, 363 (9410), 675-681. doi:10.1016/S0140-6736(04)15640-7

Leclercq, P., Hermesse, A., & Malaise, M. (2004). Fièvre méditerranéenne familiale. Revue Médicale de Liège, 59 (5), 320-325.

Leclercq, P., & Malaise, M. (2004). Le medicament du mois. Etoricoxib (Arcoxia). Revue Médicale de Liège, 59 (5), 345-349.

Leclercq, P., & Malaise, M. (2004). La goutte. Revue Médicale de Liège, 59 (5), 274-280.

Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.-J., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2004). 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Journal of Biological Chemistry, 279 (21), 399-403. doi:10.1074/jbc.M314118200

Scheen, A., & Malaise, M. (2004). Le medicament du mois. Valdecoxib (Bextra). Revue Médicale de Liège, 59 (4), 251-254.

Franchimont, N. M., Lambert, C., Ribbens, C., Huynen, P., Relic, B., Bours, V., Merville, M.-P., & Malaise, M. (September 2003). Interleukin-1beta and tumor necrosis factor-alpha enhance the shedding of Interleukin-6 receptor in osteoblastic cells: Involvement of tumor necrosis factor-alpha converting enzyme. Arthritis and Rheumatism, 48 (9, Suppl. S), 482.

Lambert, C., Ribbens, C., Bours, V., Merville, M.-P., Malaise, M., & Franchimont, N. (September 2003). Identification of the signalling pathways required for interleukin-1 beta stimulation of osteoprotegerin synthesis in osteoblastic cells. Journal of Bone and Mineral Research, 18 (Suppl. 2), 142.

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (September 2003). Raloxifene protects Osteoblasts from apoptosis induced by sodium nitroprusside: Potential involvement of ceramide. Journal of Bone and Mineral Research, 18 (Suppl. 2), 136.

Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., Bonnet, V., Beckers, C., & Malaise, M. (2003). Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. Radiology, 229 (2), 562-569. doi:10.1148/radiol.2292020206

van de Putte, L. B. A., Rau, R., Breedveld, F. C., Kalden, J. R., Malaise, M., van Riel, P. L. C. M., Schattenkirchner, M., Emery, P., Burmester, G. R., Zeidler, H., Moutsopoulos, H. M., Beck, K., & Kupper, H. (2003). Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Annals of the Rheumatic Diseases, 62 (12), 1168-1177. doi:10.1136/ard.2003.009563

Bettiol, J., Sele, J., Henket, M., Louis, E., Malaise, M., Bartsch, P., & Louis, R. (December 2002). Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma. Allergy, 57 (12), 1145-1150. doi:10.1034/j.1398-9995.2002.23586.x

Louis, E., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Pescatore, P., Fiasse, R., Pelckmans, P., Reynaert, H., D'Haens, G., Malaise, M., & Belaiche, J. (July 2002). A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism. Scandinavian Journal of Gastroenterology, 37 (7), 818-824. doi:10.1080/713786515

BECKERS, C., Foidart, J., Thiry, A., & Malaise, M. (2002). Métastase synoviale d'un cancer colique se présentant comme une arthrite du genou. Caractérisation par tomographie à émission de positons au 18FDG. Revue Médicale de Liège, 57 (5), 467-474.

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). FDG-PET imaging for monitoring rheumatoid arthritis treated by infliximab injections. Journal of Nuclear Medicine, 43, 38.

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). Characterization of inflamed joints in rheumatoid arthritis patients using FDG-PET: correlation with clinical and ultrasonographical assessment. Journal of Nuclear Medicine, 43, 38.

Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3

Kaiser, M.-J., & Malaise, M. (2002). Déminéralisation et ostéoporose: une confusion sémantique. Revue Médicale de Liège, 57 (5), 274-279.

Kaiser, M.-J., & Malaise, M. (2002). Comment je traite ... une polyarthrite rhumatoïde. L'avènement d'une nouvelle ère thérapeutique: les anticorps anti-TNF-alpha. Revue Médicale de Liège, 57 (8), 486-492.

Malaise, M., Kaye, O., Radermecker, M., Duysinx, B., Hustinx, R., Hermans, G., & de Leval, L. (2002). Une dorsalgie malheureusement tenace. Revue Médicale de Liège, 57 (5), 270-273.

Relic, B., Bentires-Alj, M., Ribbens, C., Franchimont, N., Guerne, P.-A., Benoit, V., Merville, M.-P., Bours, V., & Malaise, M. (2002). TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Laboratory Investigation, 82 (12), 1661-1672. doi:10.1097/01.LAB.0000041714.05322.C0

Ribbens, C., Martin y Porras, M., Franchimont, N., Kaiser, M.-J., Jaspar, J. M., Damas, P., Houssiau, F. A., & Malaise, M. (2002). Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Annals of the Rheumatic Diseases, 61 (2), 161-166. doi:10.1136/ard.61.2.161

VanderBorght, A., De Keyser, F., Geusens, P., De Backer, M., Malaise, M., Baeten, D., Van den Bosch, F., Veys, E. M., Raus, J., & Stinissen, P. (2002). Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral). Journal of Rheumatology, 29 (3), 416-426.

Pierard, G., Pierard-Franchimont, C., Vanderplaetsen, S., Franchimont, N., GASPARD, U., & Malaise, M. (August 2001). Relationship between bone mass density and tensile strength of the skin in women. European Journal of Clinical Investigation, 31 (8), 731-735. doi:10.1046/j.1365-2362.2001.00841.x

Denis, M. A., Louis, R., Malaise, M., Belaiche, J., & Louis, E. (February 2001). Increased Response of Blood Eosinophils to Various Chemotactic Agents in Quiescent Crohn Disease. Scandinavian Journal of Gastroenterology, 36 (2), 190-5. doi:10.1080/003655201750065951

BECKERS, C., HUSTINX, R., FOIDART-WILLEMS, J., RIGO, P., & MALAISE, M. (2001). Glucose metabolism in rheumatoid arthritis knee joints before and after anti-TNF-apha blockade : evaluation by PET with 18-FDG. IN PROCEEDINGS ANNUAL AMI MEETING 2001, P56.

Chantraine, A., Bosson, L., Malaise, M., Onkelinx, A., & de Leval, J. (2001). The occurrence of the ilio-lumbar syndrome in a spinal cord injury patient. Spinal Cord, 39 (4), 237-239. doi:10.1038/sj.sc.3101143

Emery, P., Reginster, J.-Y., Appelboom, T., Breedveld, F. C., Edelmann, E., Kekow, J., Malaise, M., Mola, E. M., Montecucco, C., Sanda, M., Sany, J., Scott, D. L., Serni, U., & Seydoux, G. (2001). WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. Rheumatology, 40 (6), 699-702. doi:10.1093/rheumatology/40.6.699

Ribbens, C., Andre, B., Kaye, O., & Malaise, M. (2001). Actualités thérapeutiques de la polyarthrite rhumatoïde. Revue de la Médecine Générale, 186, 372-376.

Ribbens, C., & Malaise, M. (2001). La stromelysine-1 en pathologie inflammatoire: signification, specificite et elements de regulation. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 156 (5-6), 275-281, discussion 281-283.

Bettiol, J., Bartsch, P., Louis, R., De Groote, D., Gevaerts, Y., Louis, E., & Malaise, M. (December 2000). Cytokine Production from Peripheral Whole Blood in Atopic and Nonatopic Asthmatics: Relationship with Blood and Sputum Eosinophilia and Serum Ige Levels. Allergy, 55 (12), 1134-41. doi:10.1034/j.1398-9995.2000.00711.x

Louis, R., Leyder, E., Malaise, M., Bartsch, P., & Louis, E. (October 2000). Lack of Association between Adult Asthma and the Tumour Necrosis Factor Alpha-308 Polymorphism Gene. European Respiratory Journal, 16 (4), 604-8. doi:10.1034/j.1399-3003.2000.16d06.x

Louis, E., Ribbens, C., Barreto Dos Santos, A., Franchimont, D., De Groote, D., Hardy, N., Boniver, J., Belaiche, J., & Malaise, M. (May 2000). Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clinical and Experimental Immunology, 120 (2), 241-246. doi:10.1046/j.1365-2249.2000.01227.x

Baron, F., Ribbens, C., Kaye, O., Fillet, G., Malaise, M., & Beguin, Y. (2000). Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. British Journal of Haematology, 110 (2), 339-342. doi:10.1046/j.1365-2141.2000.02191.x

Malaise, M. (2000). Les non-recommandations dans le traitement de l'arthrose et de la polyarthrite rhumatoïde, ou pourquoi la médecine basée sur le niveau de preuve ne s'applique pas (encore) à la rhumatologie. Revue Médicale de Liège, 55 (5), 466-475.

Ribbens, C., Andre, B., Jaspar, J. M., Kaye, O., Kaiser, M.-J., De Groote, D., & Malaise, M. (2000). Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. Journal of Rheumatology, 120 (1), 888-893.

Ribbens, C., Andre, B., Kaye, O., Kaiser, M. J., Bonnet, V., de Groote, D., Franchimont, N., & Malaise, M. (2000). Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. European Cytokine Network, 11 (4), 669-676.

Ribbens, C., Andre, B., Kaye, O., Kaiser, M. J., Bonnet, V., Jaspar, J. M., de Groote, D., Franchimont, N., & Malaise, M. (2000). Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology, 39 (12), 1357-1365. doi:10.1093/rheumatology/39.12.1357

Ribbens, C., Bonnet, V., Kaiser, M.-J., Andre, B., Kaye, O., Franchimont, N., De Groote, D., Beguin, Y., & Malaise, M. (2000). Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clinical and Experimental Immunology, 120 (1), 194-199. doi:10.1046/j.1365-2249.2000.01198.x

Chapelle, J.-P., Geenen, V., Malaise, M., Franchimont, N., Legrand, V., & Damas, P. (13 March 1999). Cytokines et nouveaux marqueurs inflammatoires [Paper presentation]. Séance de Formation continue du Département de Biologie clinique, CHU Liège, Liège, Belgium.

Bassleer, C., Combal, J. P., Bougaret, S., & Malaise, M. (May 1998). Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis and Cartilage, 6 (3), 196-204. doi:10.1053/joca.1998.0112

Louis, E., Franchimont, D., Piron, A., Gevaert, Y., Schaaf-Lafontaine, N., Roland, S., Mahieu, P., Malaise, M., De Groote, D., Louis, R., & Belaiche, J. (1998). Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clinical and Experimental Immunology, 113 (3), 401-406. doi:10.1046/j.1365-2249.1998.00662.x

Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (April 1997). Les manifestations osteo-articulaires du sujet âgé. Revue Médicale de Liège, 52 (4), 270-277.

Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (1997). Ciclosporine et maladies systémiques. Médecine et Hygiène, 55, 1510-1514.

Bassleer, C., Magotteaux, J., Geenen, V., & Malaise, M. (1997). Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes. Pharmacology, 54, 49-56. doi:10.1159/000139469

Kaye, O., Ribbens, C., Kahn, M. F., & Malaise, M. (1997). Sarcoidosis: recognition and treatment guidelines. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 7 (6), 441-447. doi:10.2165/00063030-199707060-00003

Kaye, O., BECKERS, C., Paquet, P., Arrese Estrada, J., Pierard, G., & Malaise, M. (1996). The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate. Journal of Rheumatology, 23 (2), 253-257.

Malaise, M. (January 1996). Les anti-inflammatoires non stéroïdiens. Revue Médicale de Liège, 51 (1), 123-125.

Weber, T., BECKERS, C., Kaye, O., Comhaire, Y., Malaise, M., & Dechenne, C. (1996). Néphropathie tubulo-interstitielle aigue avec uvéite: à propos d'un cas. Acta Clinica Belgica, 51 (1), 53-56.

Kaye, O., Palazzo, E., Grossin, M., Bourgeois, P., Kahn, M. F., & Malaise, M. (1995). Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. British Journal of Rheumatology, 34 (7), 642-644. doi:10.1093/rheumatology/34.7.642

Kaye, O., Ribbens, C., Hauwaert, C., & Malaise, M. (1995). Toxicité potentielle et utilisation pratique du méthotrexate dans la polyarthrite rhumatoïde. Médecine et Hygiène, 1625-1628.

Kaye, O., Ribbens, C., Hauwaert, C., & Malaise, M. (1995). Le méthotrexate en rhumatologie: une révolution thérapeutique. Revue Médicale de Liège, 50 (11), 453-457.

Malaise, M., De Keyser, P., De Backer, M., van Lierde, M. A., & Lesaffre, E. (1995). The use of Sandimmun (cyclosporin A) in severe refractory rheumatoid arthritis: the Belgian experience. Clinical Rheumatology, 14, 26-32. doi:10.1007/BF02215855

Davin, J. C., Pierard, G., Dechenne, C., Grossman, D., Nagy, J., Quacoe, M., Malaise, M., Hall, M., Jansen, F., & Chantraine, J. M. (April 1994). Possible pathogenic role of IgE in Henoch-Schonlein purpura. Pediatric Nephrology, 8 (2), 169-171. doi:10.1007/BF00865470

Beguin, Y., Lampertz, S., De Groote, D., Igot, D., Malaise, M., & Fillet, G. (1993). Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia, 7 (12), 2019-2025.

Malaise, M. (1992). Le lupus érythémateux systémique. Revue Médicale de Liège, 47 (10), 481-501.

Davin, J. C., Li Vecchi, M., Nagy, J., Foidart, J.-M., Foidart, J. B., Barbagallo Sangiorgi, G., Malaise, M., & Mahieu, P. (1991). Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in primary IgA nephropathy. Journal of Clinical Immunology, 11 (2), 78-94. doi:10.1007/BF00917744

Malaise, M. (1991). Phagocytose immune et non immune. Revue Médicale de Liège, 46 (9), 486-503.

Malaise, M., Hoyoux, C., Franchimont, P., & Mahieu, P. R. (1990). Evidence for a role of accessible galactosyl or mannosyl residues of Fc domain in the in vivo clearance of IgG antibody-coated autologous erythrocytes in the rat. Clinical Immunology and Immunopathology, 54 (3), 469-483. doi:10.1016/0090-1229(90)90059-Y

de Marneffe, P., Malaise, M., Deflandre, E., Hauwaert, C., Lallemand, M. P., & Franchimont, P. (1989). Détection et caractérisation antigènique des anticorps antinucleaires dans les connectivites. Revue Médicale de Liège, 44 (19), 577-591.

Malaise, M., Franchimont, P., & Mahieu, P. R. (1989). The ability of normal human monocytes to phagocytose IgG-coated red blood cells is related to the number of accessible galactosyl and mannosyl residues in the Fc domain of the anti-red blood cell IgG antibody molecules. Journal of Immunological Methods, 119 (2), 231-239. doi:10.1016/0022-1759(89)90401-8

Malaise, M., Hoyoux, C., Franchimont, P., Foidart, J. B., & Mahieu, P. R. (1989). Effects of mannose and mannose derivatives on the clearance of IgG antibody-coated erythrocytes in the rat. Immunology, 68 (1), 126-132.

Vecchi, M. L., Davin, J. C., Castronovo, V., Foidart, J.-M., Malaise, M., Foidart, J. B., Dechene, C., Sangiorgi, G. B., & Mahieu, P. (1989). Reactivity of human anti-alpha-galactosyl IgG antibody with alpha(1-->3)-linked galactosyl epitopes exposed on basement membranes and on glomerular epithelial cells: an in vitro and in vivo study in the mouse. Clinical and Experimental Immunology, 78 (2), 271-7.

Foidart, J. B., Davin, J. C., Malaise, M., Saint-Remy, A., & Mahieu, P. (March 1988). Stimulation of platelet lipoxygenase during hemodialysis. Kidney International. Supplement, 24, 80-S81.

Franchimont, P., Reuter, A., Vrindts-Gevaert, Y., Bastings, M., Malaise, M., Sondag, C., Frere, M. C., & Gysen, P. (1988). Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis. Scandinavian Journal of Rheumatology, 17 (3), 203-212. doi:10.3109/03009748809098783

Mahieu, P., Malaise, M., Hoyoux, C., & Davin, J. C. (1988). Influence de la grossesse sur certaines maladies auto-immunes. Revue Médicale de Liège, 43 (22), 727-736.

Malaise, M., Franchimont, P., & Mahieu, P. R. (1988). Evidence that the phagocytosis mediated by the peanut agglutinin-like activity of IgG(Fc) receptors of human monocytes is selectively modulated by estradiol and natural estrogens. Journal of Clinical Immunology, 8 (6), 495-502. doi:10.1007/BF00916956

Reuter, A., Bernier, J., Vrindts-Gevaert, Y., Meuleman-Gathy, R., Malaise, M., Fiers, W., & Franchimont, P. (1988). Production of interferon gamma by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 6 (4, Oct-Dec), 347-354.

Davin, J. C., Malaise, M., Foidart, J., & Mahieu, P. (1987). Anti-alpha-galactosyl antibodies and immune complexes in children with Henoch-Schonlein purpura or IgA nephropathy. Kidney International, 31 (5), 1132-1139. doi:10.1038/ki.1987.119

Etienne-Decerf, J., Malaise, M., Mahieu, P., & Winand, R. (1987). Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy? Acta Endocrinologica, 115 (1), 67-74. doi:10.1530/acta.0.1150067

Mahieu, P., Davin, J. C., & Malaise, M. (1987). Intérêts diagnostiques et thérapeutique des anticorps monoclonaux en néphrologie. Revue Médicale de Liège, 42 (10), 470-474.

Malaise, M., Bastings, M., Reuter, A. M., Vrindts-Gevaert, Y., Bernier, J., Sondag, D., Frere, M. C., Goldstein, G., & Franchimont, P. (1987). In vitro effects of thymopentin on the gamma-interferon production by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. Immunology Letters, 15 (4), 323-327. doi:10.1016/0165-2478(87)90136-2

Malaise, M., & Franchimont, P. (1987). Methods of clinical and biological assessment of rheumatoid arthritis. Scandinavian Journal of Rheumatology. Supplement, 65, 81-84. doi:10.3109/03009748709102181

Malaise, M., & Franchimont, P. (1987). Defective in vitro gamma-interferon production in rheumatoid arthritis [letter to the editor]. Arthritis and Rheumatism, 30 (2), 230-231. doi:10.1002/art.1780300217

Malaise, M., Franchimont, P., Bouillene, C., Houssier, C., & Mahieu, P. R. (1987). Increased concanavalin A-binding capacity of immunoglobulin G purified from sera of patients with rheumatoid arthritis. Clinical and Experimental Immunology, 68 (3), 543-551.

Malaise, M., Franchimont, P., Gomez, F., Bouillenne, C., & Mahieu, P. R. (1987). The spontaneous ability of normal human IgG to inhibit the Fc receptors of normal human monocytes is related to their binding capacity to lectins. Clinical Immunology and Immunopathology, 45 (1), 1-16. doi:10.1016/0090-1229(87)90106-1

Malaise, M., Hazee-Hagelstein, M.-T., Reuter, A. M., Vrinds-Gevaert, Y., Goldstein, G., & Franchimont, P. (1987). Thymopoietin and thymopentin enhance the levels of ACTH, beta-endorphin and beta-lipotropin from rat pituitary cells in vitro. Acta Endocrinologica, 115 (4), 455-460. doi:10.1530/acta.0.1150455

Sany, J., Clot, J., Combe, B., Franchimont, P., Malaise, M., Hauwaert, C., Dreiser, R. L., Bourgeois, P., Kahn, M. F., & Veys, E. (1987). Traitement de la polyarthrite rhumatoïde: étude comparative de l'effect des immunoglobulines G éluées du placenta et de celui des veinoglobulines. Presse Médicale, 16 (15), 723-724.

Malaise, M., Davin, J. C., Mahieu, P. R., & Franchimont, P. (1986). Elevated antigalactosyl antibody titers reflect renal injury after gold or D-penicillamine in rheumatoid arthritis. Clinical Immunology and Immunopathology, 40 (2), 356-364. doi:10.1016/0090-1229(86)90040-1

Malaise, M., Desoroux, A., Mahieu, P., & Franchimont, P. (1986). C3b receptor (CR1) on erythrocytes and the HLA-DR3 antigen [letter to the editor]. Arthritis and Rheumatism, 29 (2), 300-301. doi:10.1002/art.1780290221

Malaise, M., Franchimont, P., Houssier, C., Closset, J., Hennen, G., & Mahieu, P. R. (1986). In vitro studies on the Fc-receptor function of mononuclear phagocytes in rheumatoid arthritis: relation between the Fc-receptor blockade and the concanavalin A-binding capacity of autologous immunoglobulin G. Journal of Clinical Immunology, 6 (6), 442-456. doi:10.1007/BF00915250

Gysen, P., Malaise, M., Gaspar, S., & Franchimont, P. (1985). Measurement of proteoglycans, elastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies. Clinical Rheumatology, 4 (1), 39-50. doi:10.1007/BF02032316

Malaise, M., Foidart, J. B., Hauwaert, C., Mahieu, P., & Franchimont, P. (1985). In vivo studies on the mononuclear phagocyte system Fc receptor function in rheumatoid arthritis. Correlations with clinical and immunological variables. Journal of Rheumatology, 12 (1), 33-42.

Malaise, M., Foidart, J., Hoyoux, C., Davin, J. C., Mahieu, P., & Franchimont, P. (1985). Étude de la fonction Fc-récepteur du système mononucléé phagocytaire dans les affections immunes. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 140 (10), 362-367.

Malaise, M., Franchimont, P., Bach-Andersen, R., Gerber, H., Stocker, H., Hauwaert, C., Danneskiold-Samsoe, B., Gross, D., Gerschpacher, H., & Bolla, K. (1985). Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. Lancet, 13 (1), 832-836. doi:10.1016/S0140-6736(85)92205-6

Malaise, M., Franchimont, P., Hauwaert, C., Danneskiold-Samsoe, B., Gross, D., Gerber, H., Gerschpacher, H., & Bolla, K. (1985). Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis. Survey of Immunologic Research, 4, 87-93. doi:10.1007/BF02919062

Malaise, M., Lust, C., Foidart, J. B., & Mahieu, P. (1985). Complement activation during hemodialysis [letter to the editor]. New England Journal of Medicine, 312 (8), 514-515. doi:10.1056/NEJM198502213120813

Malaise, M., & Mahieu, P. R. (1985). The Fc-receptor function of human mononuclear phagocyte system: physiological role, alteration in immune diseases and modulation. Acta Clinica Belgica, 40 (1), 27-37. doi:10.1080/22953337.1985.11719047

Malaise, M., & Mahieu, P. (1985). Bilan minimum d'orientation dans le diagnostic immunologique. Revue Médicale de Liège, 40 (8), 288-301.

Reginster, J.-Y., Gysen, P., Malaise, M., & Franchimont, P. (1985). Modifications des proteoglycans articulaires durant traitement par l'acide tiaprofénique. Revue Médicale de Liège, 40 (17), 596-599.

Davin, J. C., Foidart, J. B., Malaise, M., & Mahieu, P. R. (1984). Intérêt de la mesure de la fonction du récepteur Fc des monocytes circulants et des macrophages spléniques dans les néphropathies glomérulaires de l'enfant. Revue Médicale de Liège, 39 (8), 332-334.

Malaise, M., Franchimont, P., Hauwaert, C., Danneskiold-Samsoe, B., Gross, D., Gerber, H., Gerschpacher, H., & Bolla, K. (1984). Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis. International Journal of Clinical Pharmacology, Therapy and Toxicology, 4 (6), 451-457.

Hoyoux, P., Malaise, M., Kinet, J. P., Balland, N., Sondags, D., Frere, M. C., Mahieu, P., & Andre, A. (1982). Intérêt thérapeutique des techniques de plasmaphérèse. Revue Médicale de Liège, 37 (8), 303-312.